Sara Miller
Concepts (723)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wasps | 7 | 2023 | 23 | 2.800 |
Why?
| | Selection, Genetic | 6 | 2025 | 259 | 2.580 |
Why?
| | Alcohol Drinking | 8 | 2026 | 836 | 2.420 |
Why?
| | Cognition | 8 | 2026 | 1262 | 1.890 |
Why?
| | Biological Evolution | 6 | 2025 | 466 | 1.850 |
Why?
| | Smegmamorpha | 4 | 2019 | 6 | 1.800 |
Why?
| | Behavior, Animal | 4 | 2021 | 519 | 1.210 |
Why?
| | Coronavirus | 2 | 2020 | 47 | 1.200 |
Why?
| | Hemostatics | 2 | 2026 | 64 | 1.120 |
Why?
| | Coronavirus Infections | 5 | 2020 | 382 | 1.120 |
Why?
| | Microscopy, Electron | 11 | 2022 | 414 | 1.110 |
Why?
| | Pneumonia, Viral | 4 | 2020 | 388 | 1.010 |
Why?
| | Substance Abuse, Intravenous | 2 | 2025 | 127 | 1.010 |
Why?
| | Postpartum Hemorrhage | 1 | 2026 | 28 | 0.940 |
Why?
| | Memory Disorders | 3 | 2023 | 197 | 0.930 |
Why?
| | Surgery, Computer-Assisted | 3 | 2018 | 84 | 0.890 |
Why?
| | Pandemics | 7 | 2024 | 1703 | 0.870 |
Why?
| | Microscopy, Electron, Transmission | 6 | 2021 | 155 | 0.870 |
Why?
| | Genetic Fitness | 1 | 2025 | 56 | 0.860 |
Why?
| | Substance-Related Disorders | 3 | 2023 | 1093 | 0.840 |
Why?
| | Academic Performance | 1 | 2024 | 15 | 0.820 |
Why?
| | Optical Imaging | 3 | 2019 | 61 | 0.800 |
Why?
| | Diabetes, Gestational | 2 | 2025 | 305 | 0.800 |
Why?
| | Individuality | 1 | 2025 | 149 | 0.780 |
Why?
| | Amnesia, Anterograde | 1 | 2023 | 7 | 0.770 |
Why?
| | Humans | 97 | 2026 | 145140 | 0.730 |
Why?
| | Placenta Accreta | 1 | 2022 | 29 | 0.730 |
Why?
| | Pre-Exposure Prophylaxis | 1 | 2025 | 268 | 0.720 |
Why?
| | Prescription Drug Misuse | 1 | 2023 | 52 | 0.720 |
Why?
| | Hydrogels | 2 | 2026 | 701 | 0.720 |
Why?
| | Betacoronavirus | 4 | 2020 | 287 | 0.700 |
Why?
| | Archives | 1 | 2021 | 5 | 0.700 |
Why?
| | Entomology | 1 | 2021 | 4 | 0.680 |
Why?
| | Ethology | 1 | 2021 | 3 | 0.680 |
Why?
| | Cellular Structures | 1 | 2021 | 6 | 0.670 |
Why?
| | Data Curation | 1 | 2021 | 21 | 0.670 |
Why?
| | Life History Traits | 1 | 2021 | 15 | 0.660 |
Why?
| | Genetic Variation | 4 | 2024 | 967 | 0.650 |
Why?
| | Insecta | 1 | 2021 | 71 | 0.650 |
Why?
| | Behavior, Addictive | 1 | 2021 | 88 | 0.640 |
Why?
| | Animals | 47 | 2026 | 37952 | 0.640 |
Why?
| | Genome | 2 | 2022 | 304 | 0.640 |
Why?
| | Erythrocyte Transfusion | 1 | 2022 | 225 | 0.640 |
Why?
| | Gestational Age | 1 | 2024 | 987 | 0.630 |
Why?
| | Animal Communication | 1 | 2020 | 18 | 0.630 |
Why?
| | Ecology | 1 | 2021 | 105 | 0.620 |
Why?
| | Infant, Premature | 2 | 2024 | 619 | 0.620 |
Why?
| | Academic Success | 1 | 2019 | 30 | 0.600 |
Why?
| | Food Chain | 2 | 2019 | 36 | 0.590 |
Why?
| | Perciformes | 1 | 2019 | 20 | 0.570 |
Why?
| | Infant, Low Birth Weight | 1 | 2019 | 156 | 0.570 |
Why?
| | Animal Distribution | 1 | 2019 | 27 | 0.560 |
Why?
| | Female | 50 | 2026 | 78636 | 0.550 |
Why?
| | Hip | 1 | 2018 | 57 | 0.540 |
Why?
| | Sex Characteristics | 1 | 2023 | 775 | 0.530 |
Why?
| | Opioid-Related Disorders | 1 | 2025 | 600 | 0.510 |
Why?
| | Diagnostic Techniques, Ophthalmological | 1 | 2017 | 53 | 0.510 |
Why?
| | United States | 14 | 2025 | 16065 | 0.500 |
Why?
| | Amputees | 1 | 2018 | 98 | 0.500 |
Why?
| | Optic Nerve Diseases | 1 | 2017 | 49 | 0.500 |
Why?
| | Optic Disk | 1 | 2017 | 53 | 0.500 |
Why?
| | Photography | 1 | 2017 | 119 | 0.490 |
Why?
| | Stress, Psychological | 1 | 2025 | 1145 | 0.480 |
Why?
| | Practice Patterns, Physicians' | 1 | 2025 | 1365 | 0.460 |
Why?
| | Child Development | 2 | 2019 | 483 | 0.450 |
Why?
| | Male | 40 | 2026 | 72664 | 0.450 |
Why?
| | Ecosystem | 1 | 2019 | 478 | 0.450 |
Why?
| | Caregivers | 2 | 2021 | 1070 | 0.440 |
Why?
| | Students, Medical | 5 | 2021 | 376 | 0.440 |
Why?
| | Postural Balance | 1 | 2018 | 244 | 0.440 |
Why?
| | Gait | 1 | 2018 | 312 | 0.440 |
Why?
| | Executive Function | 1 | 2019 | 469 | 0.430 |
Why?
| | Artificial Limbs | 1 | 2018 | 203 | 0.430 |
Why?
| | Glioblastoma | 1 | 2018 | 352 | 0.420 |
Why?
| | Phenotype | 5 | 2023 | 3138 | 0.420 |
Why?
| | Molecular Imaging | 3 | 2019 | 57 | 0.410 |
Why?
| | Lower Extremity | 1 | 2018 | 440 | 0.410 |
Why?
| | Glaucoma | 1 | 2017 | 250 | 0.410 |
Why?
| | HIV Infections | 3 | 2025 | 3186 | 0.410 |
Why?
| | Genetics, Population | 3 | 2020 | 216 | 0.400 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2021 | 890 | 0.380 |
Why?
| | Longitudinal Studies | 4 | 2025 | 2949 | 0.350 |
Why?
| | Catheter-Related Infections | 1 | 2012 | 96 | 0.340 |
Why?
| | Neoplasms | 2 | 2021 | 2900 | 0.330 |
Why?
| | Lung | 2 | 2022 | 4101 | 0.330 |
Why?
| | Bioterrorism | 3 | 2009 | 31 | 0.330 |
Why?
| | Infection Control | 1 | 2012 | 173 | 0.320 |
Why?
| | General Surgery | 3 | 2018 | 206 | 0.320 |
Why?
| | Comprehensive Health Care | 1 | 2010 | 22 | 0.320 |
Why?
| | Genome, Insect | 2 | 2021 | 28 | 0.320 |
Why?
| | Education, Medical, Undergraduate | 3 | 2018 | 207 | 0.320 |
Why?
| | Catheterization, Central Venous | 1 | 2012 | 123 | 0.320 |
Why?
| | National Health Programs | 2 | 2009 | 23 | 0.320 |
Why?
| | Public Policy | 1 | 2010 | 80 | 0.310 |
Why?
| | Endocytosis | 3 | 2022 | 168 | 0.310 |
Why?
| | Bacteremia | 1 | 2012 | 222 | 0.310 |
Why?
| | Social Behavior | 3 | 2023 | 284 | 0.300 |
Why?
| | Adult | 19 | 2026 | 40665 | 0.300 |
Why?
| | Health Plan Implementation | 1 | 2010 | 141 | 0.300 |
Why?
| | Mitochondria, Heart | 2 | 2025 | 105 | 0.300 |
Why?
| | Curriculum | 5 | 2021 | 1067 | 0.300 |
Why?
| | Fluorescent Dyes | 4 | 2019 | 333 | 0.280 |
Why?
| | Dental Implantation, Endosseous | 1 | 2008 | 3 | 0.280 |
Why?
| | Brain Neoplasms | 1 | 2018 | 1328 | 0.280 |
Why?
| | Dental Prosthesis, Implant-Supported | 1 | 2008 | 7 | 0.280 |
Why?
| | Middle Aged | 14 | 2025 | 36126 | 0.280 |
Why?
| | Intraoperative Care | 2 | 2019 | 63 | 0.270 |
Why?
| | Hemorrhage | 2 | 2026 | 822 | 0.270 |
Why?
| | Career Choice | 3 | 2020 | 234 | 0.260 |
Why?
| | Viruses | 1 | 2009 | 164 | 0.260 |
Why?
| | Virus Diseases | 1 | 2009 | 216 | 0.250 |
Why?
| | BK Virus | 3 | 2013 | 18 | 0.250 |
Why?
| | Polyomavirus Infections | 3 | 2013 | 30 | 0.250 |
Why?
| | Tumor Virus Infections | 3 | 2013 | 50 | 0.250 |
Why?
| | Glucose Tolerance Test | 2 | 2025 | 360 | 0.240 |
Why?
| | Myocytes, Cardiac | 2 | 2025 | 544 | 0.240 |
Why?
| | Child Behavior | 2 | 2019 | 236 | 0.240 |
Why?
| | Sirtuin 2 | 1 | 2026 | 28 | 0.240 |
Why?
| | Nanocomposites | 1 | 2026 | 14 | 0.240 |
Why?
| | Alcohol Drinking in College | 1 | 2026 | 18 | 0.230 |
Why?
| | Aged | 9 | 2025 | 26096 | 0.230 |
Why?
| | Prospective Studies | 5 | 2023 | 8035 | 0.230 |
Why?
| | Endodontists | 1 | 2025 | 1 | 0.230 |
Why?
| | Endodontics | 1 | 2025 | 4 | 0.230 |
Why?
| | Technology, Dental | 1 | 2025 | 5 | 0.230 |
Why?
| | Infant, Newborn | 6 | 2024 | 6435 | 0.230 |
Why?
| | Herpesvirus 4, Human | 1 | 2026 | 172 | 0.230 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 4 | 1 | 2025 | 2 | 0.220 |
Why?
| | Glutamate Carboxypeptidase II | 1 | 2025 | 8 | 0.220 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2026 | 101 | 0.220 |
Why?
| | Blood Glucose | 3 | 2025 | 2335 | 0.220 |
Why?
| | Uterus | 1 | 2026 | 226 | 0.220 |
Why?
| | Pregnancy | 5 | 2025 | 7182 | 0.220 |
Why?
| | Surveys and Questionnaires | 5 | 2025 | 6055 | 0.210 |
Why?
| | Carcinoma, Pancreatic Ductal | 2 | 2019 | 293 | 0.210 |
Why?
| | Antigens, Surface | 1 | 2025 | 155 | 0.210 |
Why?
| | Prostatic Neoplasms, Castration-Resistant | 1 | 2025 | 52 | 0.210 |
Why?
| | Printing, Three-Dimensional | 1 | 2025 | 100 | 0.210 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2025 | 224 | 0.210 |
Why?
| | Autophagy | 4 | 2010 | 288 | 0.210 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2025 | 123 | 0.210 |
Why?
| | Apolipoprotein L1 | 1 | 2024 | 14 | 0.210 |
Why?
| | Motivational Interviewing | 1 | 2025 | 121 | 0.200 |
Why?
| | Spectroscopy, Near-Infrared | 3 | 2019 | 70 | 0.200 |
Why?
| | Virion | 2 | 2020 | 108 | 0.200 |
Why?
| | Cetuximab | 3 | 2019 | 111 | 0.200 |
Why?
| | Fibroblast Growth Factors | 1 | 2025 | 188 | 0.200 |
Why?
| | alpha-Synuclein | 1 | 2023 | 45 | 0.200 |
Why?
| | Haploidy | 1 | 2023 | 28 | 0.200 |
Why?
| | Diploidy | 1 | 2023 | 16 | 0.200 |
Why?
| | Adenosine Triphosphatases | 3 | 2009 | 159 | 0.200 |
Why?
| | Variola virus | 1 | 2003 | 3 | 0.200 |
Why?
| | Transport Vesicles | 2 | 2018 | 22 | 0.200 |
Why?
| | Smallpox | 1 | 2003 | 10 | 0.200 |
Why?
| | Herpesviridae | 1 | 2003 | 21 | 0.190 |
Why?
| | Health Care Surveys | 1 | 2025 | 535 | 0.190 |
Why?
| | Virus Replication | 3 | 2023 | 519 | 0.190 |
Why?
| | Vaping | 1 | 2024 | 69 | 0.190 |
Why?
| | Disaster Planning | 2 | 2006 | 101 | 0.190 |
Why?
| | Carrier Proteins | 2 | 2022 | 728 | 0.190 |
Why?
| | Parents | 2 | 2024 | 1401 | 0.190 |
Why?
| | Mass Screening | 2 | 2025 | 1354 | 0.190 |
Why?
| | Reproducibility of Results | 3 | 2021 | 3410 | 0.190 |
Why?
| | Obstetrics | 1 | 2025 | 177 | 0.190 |
Why?
| | Guinea | 1 | 2022 | 3 | 0.190 |
Why?
| | Internal-External Control | 1 | 2023 | 74 | 0.190 |
Why?
| | Feeding Behavior | 2 | 2019 | 689 | 0.190 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2024 | 108 | 0.180 |
Why?
| | Ventricular Remodeling | 1 | 2025 | 277 | 0.180 |
Why?
| | Immunosenescence | 1 | 2022 | 5 | 0.180 |
Why?
| | Rats | 4 | 2026 | 5582 | 0.180 |
Why?
| | Cell Cycle Proteins | 4 | 2018 | 629 | 0.180 |
Why?
| | Mice | 20 | 2026 | 18303 | 0.180 |
Why?
| | Self Report | 2 | 2026 | 867 | 0.180 |
Why?
| | Nucleocapsid | 1 | 2022 | 19 | 0.180 |
Why?
| | Gene Frequency | 1 | 2023 | 484 | 0.180 |
Why?
| | Herpesviridae Infections | 1 | 2003 | 148 | 0.180 |
Why?
| | B-Lymphocytes | 2 | 2026 | 866 | 0.180 |
Why?
| | Clinical Competence | 3 | 2020 | 1240 | 0.180 |
Why?
| | Retrospective Studies | 6 | 2023 | 17247 | 0.170 |
Why?
| | Biocompatible Materials | 1 | 2026 | 429 | 0.170 |
Why?
| | Hysterectomy | 1 | 2022 | 138 | 0.170 |
Why?
| | Nephrotic Syndrome | 1 | 2022 | 43 | 0.170 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2025 | 1742 | 0.170 |
Why?
| | Muscle Proteins | 3 | 2008 | 242 | 0.170 |
Why?
| | Natural History | 1 | 2021 | 3 | 0.170 |
Why?
| | Killer Cells, Natural | 1 | 2025 | 478 | 0.170 |
Why?
| | Medication Adherence | 1 | 2025 | 540 | 0.170 |
Why?
| | Ethanol | 2 | 2023 | 631 | 0.170 |
Why?
| | Receptors, Odorant | 1 | 2021 | 32 | 0.170 |
Why?
| | Pediatric Obesity | 2 | 2019 | 637 | 0.170 |
Why?
| | Podocytes | 1 | 2022 | 80 | 0.170 |
Why?
| | Models, Biological | 5 | 2020 | 1763 | 0.170 |
Why?
| | Autopsy | 1 | 2021 | 94 | 0.170 |
Why?
| | Nanospheres | 1 | 2020 | 3 | 0.160 |
Why?
| | Thorax | 1 | 2020 | 51 | 0.160 |
Why?
| | Cities | 1 | 2021 | 138 | 0.160 |
Why?
| | Myositis, Inclusion Body | 3 | 2010 | 11 | 0.160 |
Why?
| | Cesarean Section | 1 | 2022 | 229 | 0.160 |
Why?
| | Rats, Sprague-Dawley | 1 | 2026 | 2524 | 0.160 |
Why?
| | Epithelium | 2 | 2023 | 310 | 0.160 |
Why?
| | Infant, Premature, Diseases | 1 | 2022 | 113 | 0.160 |
Why?
| | Lip | 1 | 2020 | 23 | 0.160 |
Why?
| | Biopsy | 3 | 2021 | 1079 | 0.160 |
Why?
| | Hallucinogens | 1 | 2022 | 111 | 0.160 |
Why?
| | Mutation Rate | 1 | 2020 | 30 | 0.160 |
Why?
| | Thrombocytopenia | 2 | 2020 | 204 | 0.160 |
Why?
| | Multivariate Analysis | 1 | 2024 | 1546 | 0.160 |
Why?
| | Health Behavior | 2 | 2023 | 787 | 0.160 |
Why?
| | Texas | 1 | 2021 | 272 | 0.160 |
Why?
| | Students | 1 | 2026 | 650 | 0.160 |
Why?
| | Commission on Professional and Hospital Activities | 1 | 2020 | 4 | 0.160 |
Why?
| | Breeding | 1 | 2020 | 63 | 0.160 |
Why?
| | Kidney Transplantation | 3 | 2013 | 710 | 0.160 |
Why?
| | Tendons | 1 | 2021 | 130 | 0.160 |
Why?
| | Muscle, Skeletal | 5 | 2018 | 1789 | 0.160 |
Why?
| | Interferon Regulatory Factors | 1 | 2020 | 44 | 0.150 |
Why?
| | Pancreatic Neoplasms | 2 | 2019 | 926 | 0.150 |
Why?
| | Virus Assembly | 1 | 2020 | 81 | 0.150 |
Why?
| | Cell Surface Extensions | 1 | 2019 | 13 | 0.150 |
Why?
| | Albumins | 1 | 2020 | 119 | 0.150 |
Why?
| | Seawater | 1 | 2019 | 33 | 0.150 |
Why?
| | Fresh Water | 1 | 2019 | 53 | 0.150 |
Why?
| | Kidney Diseases | 1 | 2024 | 424 | 0.150 |
Why?
| | Transfection | 3 | 2018 | 926 | 0.150 |
Why?
| | Kidney Tubules, Proximal | 1 | 2020 | 130 | 0.150 |
Why?
| | Maternal Health Services | 1 | 2021 | 101 | 0.150 |
Why?
| | Extracellular Vesicles | 1 | 2022 | 169 | 0.150 |
Why?
| | Benchmarking | 1 | 2021 | 188 | 0.150 |
Why?
| | Cleft Lip | 1 | 2020 | 72 | 0.150 |
Why?
| | Enteral Nutrition | 1 | 2022 | 217 | 0.150 |
Why?
| | Adult Stem Cells | 1 | 2019 | 40 | 0.150 |
Why?
| | Educational Measurement | 2 | 2020 | 324 | 0.150 |
Why?
| | Cysts | 1 | 2020 | 112 | 0.150 |
Why?
| | China | 1 | 2020 | 269 | 0.150 |
Why?
| | Fibrinogen | 1 | 2020 | 180 | 0.150 |
Why?
| | Blood Transfusion | 1 | 2022 | 407 | 0.150 |
Why?
| | Geography | 1 | 2019 | 185 | 0.150 |
Why?
| | Specialties, Surgical | 1 | 2020 | 82 | 0.150 |
Why?
| | Zebrafish | 3 | 2022 | 532 | 0.150 |
Why?
| | Satiety Response | 1 | 2019 | 11 | 0.150 |
Why?
| | Cleft Palate | 1 | 2020 | 90 | 0.150 |
Why?
| | Species Specificity | 1 | 2020 | 545 | 0.140 |
Why?
| | Kingella kingae | 2 | 2009 | 12 | 0.140 |
Why?
| | Hyperphagia | 1 | 2019 | 38 | 0.140 |
Why?
| | Antineoplastic Agents, Immunological | 2 | 2018 | 198 | 0.140 |
Why?
| | Fimbriae, Bacterial | 2 | 2009 | 36 | 0.140 |
Why?
| | Abnormalities, Multiple | 1 | 2020 | 197 | 0.140 |
Why?
| | Staining and Labeling | 2 | 2012 | 153 | 0.140 |
Why?
| | Brain | 3 | 2021 | 2934 | 0.140 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 1 | 2018 | 36 | 0.140 |
Why?
| | Exons | 2 | 2021 | 363 | 0.140 |
Why?
| | Lipid Metabolism | 1 | 2022 | 529 | 0.140 |
Why?
| | Gene Expression Regulation, Leukemic | 1 | 2018 | 56 | 0.140 |
Why?
| | Harassment, Non-Sexual | 1 | 2018 | 1 | 0.140 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2025 | 661 | 0.140 |
Why?
| | Drug Approval | 1 | 2018 | 93 | 0.140 |
Why?
| | RNA, Viral | 2 | 2020 | 690 | 0.140 |
Why?
| | Young Adult | 6 | 2026 | 14176 | 0.140 |
Why?
| | Predictive Value of Tests | 2 | 2021 | 2115 | 0.140 |
Why?
| | Child | 7 | 2024 | 22670 | 0.140 |
Why?
| | Family Relations | 1 | 2018 | 87 | 0.140 |
Why?
| | Violence | 1 | 2021 | 278 | 0.130 |
Why?
| | Anti-HIV Agents | 1 | 2025 | 908 | 0.130 |
Why?
| | Age Factors | 1 | 2025 | 3338 | 0.130 |
Why?
| | Endodeoxyribonucleases | 1 | 2018 | 77 | 0.130 |
Why?
| | Inclusion Bodies | 3 | 2023 | 27 | 0.130 |
Why?
| | Bacterial Adhesion | 2 | 2008 | 108 | 0.130 |
Why?
| | Predatory Behavior | 2 | 2015 | 52 | 0.130 |
Why?
| | Biomechanical Phenomena | 2 | 2018 | 856 | 0.130 |
Why?
| | Mitochondria | 2 | 2026 | 992 | 0.130 |
Why?
| | Nepal | 1 | 2017 | 32 | 0.130 |
Why?
| | Muscular Dystrophies, Limb-Girdle | 2 | 2008 | 6 | 0.130 |
Why?
| | Caveolae | 1 | 2017 | 16 | 0.130 |
Why?
| | Prostatic Neoplasms | 1 | 2025 | 978 | 0.130 |
Why?
| | Fishes | 2 | 2015 | 109 | 0.130 |
Why?
| | Notochord | 1 | 2017 | 14 | 0.130 |
Why?
| | Indoles | 2 | 2019 | 507 | 0.130 |
Why?
| | Memory, Short-Term | 1 | 2019 | 267 | 0.130 |
Why?
| | Multimodal Imaging | 1 | 2018 | 129 | 0.130 |
Why?
| | Hematopoiesis | 1 | 2018 | 193 | 0.130 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2021 | 438 | 0.130 |
Why?
| | Parkinson Disease | 1 | 2023 | 599 | 0.130 |
Why?
| | Mycobacterium marinum | 1 | 2016 | 4 | 0.130 |
Why?
| | Lipids | 1 | 2022 | 706 | 0.120 |
Why?
| | Child, Preschool | 6 | 2024 | 11835 | 0.120 |
Why?
| | Fractures, Bone | 1 | 2022 | 426 | 0.120 |
Why?
| | Family | 1 | 2021 | 682 | 0.120 |
Why?
| | Gene Flow | 1 | 2017 | 86 | 0.120 |
Why?
| | Observer Variation | 1 | 2017 | 356 | 0.120 |
Why?
| | Clinical Clerkship | 1 | 2018 | 109 | 0.120 |
Why?
| | Fluorescein Angiography | 1 | 2017 | 190 | 0.120 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2016 | 47 | 0.120 |
Why?
| | Alcoholism | 1 | 2023 | 819 | 0.120 |
Why?
| | Platelet-Derived Growth Factor | 2 | 2006 | 85 | 0.120 |
Why?
| | Lymph Nodes | 1 | 2019 | 502 | 0.120 |
Why?
| | British Columbia | 1 | 2015 | 24 | 0.120 |
Why?
| | Pancreatectomy | 1 | 2019 | 287 | 0.120 |
Why?
| | Adaptation, Physiological | 1 | 2019 | 560 | 0.110 |
Why?
| | Mutation | 8 | 2018 | 4071 | 0.110 |
Why?
| | Learning | 1 | 2020 | 443 | 0.110 |
Why?
| | Cell Differentiation | 4 | 2021 | 2040 | 0.110 |
Why?
| | Cannabis | 1 | 2022 | 509 | 0.110 |
Why?
| | Hypoglycemic Agents | 1 | 2025 | 1393 | 0.110 |
Why?
| | Interprofessional Relations | 1 | 2018 | 275 | 0.110 |
Why?
| | Accidental Falls | 1 | 2018 | 225 | 0.110 |
Why?
| | Intestinal Mucosa | 2 | 2019 | 674 | 0.110 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2016 | 142 | 0.110 |
Why?
| | Oxidative Stress | 1 | 2022 | 1351 | 0.110 |
Why?
| | Simulation Training | 1 | 2017 | 135 | 0.110 |
Why?
| | Indians, North American | 2 | 2010 | 598 | 0.110 |
Why?
| | Poverty | 1 | 2019 | 525 | 0.110 |
Why?
| | Mental Health | 1 | 2021 | 791 | 0.110 |
Why?
| | Parenting | 1 | 2018 | 319 | 0.110 |
Why?
| | Aged, 80 and over | 2 | 2025 | 8318 | 0.110 |
Why?
| | Urine | 2 | 2012 | 64 | 0.110 |
Why?
| | Myocardial Ischemia | 1 | 2016 | 285 | 0.110 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2014 | 47 | 0.100 |
Why?
| | Insulin | 1 | 2025 | 2510 | 0.100 |
Why?
| | Respiratory Syncytial Viruses | 1 | 2014 | 58 | 0.100 |
Why?
| | Motor Cortex | 1 | 2014 | 65 | 0.100 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 2026 | 0.100 |
Why?
| | Kidney | 1 | 2021 | 1494 | 0.100 |
Why?
| | Adolescent Behavior | 1 | 2018 | 494 | 0.100 |
Why?
| | Endoribonucleases | 1 | 2014 | 77 | 0.100 |
Why?
| | Acute Kidney Injury | 1 | 2021 | 872 | 0.100 |
Why?
| | Ubiquitin | 3 | 2009 | 83 | 0.100 |
Why?
| | DNA Methylation | 1 | 2018 | 667 | 0.100 |
Why?
| | Sensitivity and Specificity | 1 | 2018 | 1995 | 0.100 |
Why?
| | Wound Healing | 3 | 2021 | 354 | 0.100 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2014 | 118 | 0.100 |
Why?
| | Fatty Acids | 1 | 2016 | 457 | 0.100 |
Why?
| | Methylene Blue | 1 | 2012 | 24 | 0.100 |
Why?
| | Antisepsis | 1 | 2012 | 1 | 0.090 |
Why?
| | Risk Factors | 4 | 2024 | 10857 | 0.090 |
Why?
| | Molecular Motor Proteins | 1 | 2012 | 37 | 0.090 |
Why?
| | Chlorhexidine | 1 | 2012 | 23 | 0.090 |
Why?
| | Heart | 1 | 2016 | 626 | 0.090 |
Why?
| | Pelvic Pain | 1 | 2012 | 42 | 0.090 |
Why?
| | Cell Line | 7 | 2018 | 2821 | 0.090 |
Why?
| | Endometriosis | 1 | 2012 | 57 | 0.090 |
Why?
| | Respiratory Syncytial Virus Infections | 1 | 2014 | 139 | 0.090 |
Why?
| | Internship and Residency | 2 | 2020 | 1264 | 0.090 |
Why?
| | Neural Stem Cells | 1 | 2014 | 168 | 0.090 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2019 | 2136 | 0.090 |
Why?
| | Equipment Contamination | 1 | 2012 | 67 | 0.090 |
Why?
| | Myelin Sheath | 1 | 2014 | 166 | 0.090 |
Why?
| | Recovery of Function | 1 | 2016 | 715 | 0.090 |
Why?
| | Mutation, Missense | 2 | 2010 | 335 | 0.090 |
Why?
| | Oligodendroglia | 1 | 2014 | 190 | 0.090 |
Why?
| | Sleep | 1 | 2019 | 887 | 0.090 |
Why?
| | Tissue Engineering | 2 | 2025 | 439 | 0.090 |
Why?
| | Myosin Heavy Chains | 1 | 2012 | 183 | 0.090 |
Why?
| | Receptors, Progesterone | 1 | 2013 | 243 | 0.090 |
Why?
| | Infant | 3 | 2022 | 10060 | 0.090 |
Why?
| | Peptides | 4 | 2013 | 997 | 0.080 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2018 | 686 | 0.080 |
Why?
| | Program Evaluation | 2 | 2017 | 943 | 0.080 |
Why?
| | Myocardium | 1 | 2016 | 931 | 0.080 |
Why?
| | Guam | 1 | 2010 | 16 | 0.080 |
Why?
| | Oklahoma | 1 | 2010 | 21 | 0.080 |
Why?
| | Multienzyme Complexes | 1 | 2010 | 65 | 0.080 |
Why?
| | DNA, Viral | 1 | 2012 | 355 | 0.080 |
Why?
| | Mice, Transgenic | 5 | 2024 | 2185 | 0.080 |
Why?
| | Microscopy, Immunoelectron | 2 | 2022 | 43 | 0.080 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2013 | 258 | 0.080 |
Why?
| | Cell Line, Tumor | 5 | 2025 | 3539 | 0.080 |
Why?
| | Muscle Weakness | 2 | 2010 | 92 | 0.080 |
Why?
| | Fish Diseases | 1 | 2010 | 17 | 0.080 |
Why?
| | Knowledge | 2 | 2021 | 57 | 0.080 |
Why?
| | Fluorescent Antibody Technique | 2 | 2022 | 365 | 0.080 |
Why?
| | Osteitis Deformans | 1 | 2009 | 9 | 0.080 |
Why?
| | Arthrogryposis | 1 | 2010 | 17 | 0.080 |
Why?
| | Anti-Infective Agents | 1 | 2012 | 232 | 0.080 |
Why?
| | Immunohistochemistry | 3 | 2022 | 1713 | 0.080 |
Why?
| | Health Care Reform | 1 | 2010 | 109 | 0.080 |
Why?
| | RNA Polymerase Sigma 54 | 1 | 2009 | 3 | 0.070 |
Why?
| | Adolescent | 6 | 2026 | 22479 | 0.070 |
Why?
| | Computer Simulation | 2 | 2018 | 1002 | 0.070 |
Why?
| | Fimbriae Proteins | 1 | 2009 | 25 | 0.070 |
Why?
| | Case-Control Studies | 4 | 2022 | 3616 | 0.070 |
Why?
| | Frontotemporal Dementia | 1 | 2009 | 55 | 0.070 |
Why?
| | Breast Neoplasms | 1 | 2022 | 2380 | 0.070 |
Why?
| | Luciferases | 1 | 2009 | 152 | 0.070 |
Why?
| | Disease Models, Animal | 4 | 2025 | 4552 | 0.070 |
Why?
| | Norwalk virus | 1 | 2008 | 1 | 0.070 |
Why?
| | Macrophages | 1 | 2016 | 1500 | 0.070 |
Why?
| | Quadriceps Muscle | 1 | 2009 | 120 | 0.070 |
Why?
| | History, 21st Century | 1 | 2009 | 220 | 0.070 |
Why?
| | Biological Assay | 1 | 2009 | 129 | 0.070 |
Why?
| | Dental Abutments | 1 | 2008 | 1 | 0.070 |
Why?
| | Denture, Partial, Immediate | 1 | 2008 | 2 | 0.070 |
Why?
| | Dental Prosthesis Design | 1 | 2008 | 2 | 0.070 |
Why?
| | Dental Restoration Failure | 1 | 2008 | 6 | 0.070 |
Why?
| | Gene Expression Regulation, Viral | 2 | 2014 | 93 | 0.070 |
Why?
| | Genes, Reporter | 1 | 2009 | 277 | 0.070 |
Why?
| | Haemophilus | 1 | 2008 | 7 | 0.070 |
Why?
| | Receptors, Tumor Necrosis Factor, Type II | 1 | 2008 | 41 | 0.070 |
Why?
| | Cyclic GMP-Dependent Protein Kinases | 1 | 2008 | 4 | 0.070 |
Why?
| | Maxilla | 1 | 2008 | 36 | 0.070 |
Why?
| | Fas Ligand Protein | 1 | 2008 | 60 | 0.070 |
Why?
| | Incisor | 1 | 2008 | 22 | 0.070 |
Why?
| | History, 20th Century | 1 | 2009 | 327 | 0.070 |
Why?
| | Mice, Inbred C57BL | 5 | 2025 | 5972 | 0.070 |
Why?
| | Computer-Aided Design | 1 | 2008 | 40 | 0.070 |
Why?
| | TNF-Related Apoptosis-Inducing Ligand | 1 | 2008 | 54 | 0.070 |
Why?
| | Transcriptome | 1 | 2014 | 1029 | 0.070 |
Why?
| | Adhesins, Bacterial | 1 | 2008 | 44 | 0.070 |
Why?
| | Microscopy, Fluorescence | 2 | 2019 | 408 | 0.070 |
Why?
| | Gastroenteritis | 1 | 2008 | 63 | 0.070 |
Why?
| | Models, Anatomic | 1 | 2008 | 87 | 0.070 |
Why?
| | Cell Membrane | 2 | 2016 | 707 | 0.060 |
Why?
| | Health Policy | 1 | 2010 | 400 | 0.060 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2008 | 125 | 0.060 |
Why?
| | Molecular Sequence Data | 5 | 2010 | 2881 | 0.060 |
Why?
| | Adenocarcinoma | 1 | 2013 | 920 | 0.060 |
Why?
| | Myofibrils | 1 | 2006 | 49 | 0.060 |
Why?
| | Sentinel Surveillance | 1 | 2006 | 46 | 0.060 |
Why?
| | Population Surveillance | 1 | 2009 | 484 | 0.060 |
Why?
| | Bone Regeneration | 1 | 2006 | 27 | 0.060 |
Why?
| | Communicable Diseases, Emerging | 1 | 2006 | 39 | 0.060 |
Why?
| | Periodontitis | 1 | 2006 | 55 | 0.060 |
Why?
| | Cells, Cultured | 2 | 2025 | 4142 | 0.060 |
Why?
| | Cytoskeletal Proteins | 1 | 2006 | 156 | 0.060 |
Why?
| | Immune Tolerance | 1 | 2008 | 385 | 0.060 |
Why?
| | Acetylation | 1 | 2026 | 259 | 0.060 |
Why?
| | Phosphoproteins | 1 | 2008 | 337 | 0.060 |
Why?
| | Antilymphocyte Serum | 2 | 2021 | 57 | 0.060 |
Why?
| | Follow-Up Studies | 4 | 2020 | 5411 | 0.060 |
Why?
| | Cross-Sectional Studies | 1 | 2017 | 5886 | 0.060 |
Why?
| | Rabbits | 2 | 2022 | 652 | 0.060 |
Why?
| | Bacterial Proteins | 2 | 2009 | 962 | 0.060 |
Why?
| | Periodontal Diseases | 1 | 2006 | 62 | 0.060 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2008 | 445 | 0.060 |
Why?
| | Laboratories | 1 | 2006 | 110 | 0.060 |
Why?
| | Gelatin | 1 | 2025 | 56 | 0.060 |
Why?
| | Lymphoma, B-Cell | 1 | 2026 | 137 | 0.050 |
Why?
| | Binge Drinking | 1 | 2025 | 45 | 0.050 |
Why?
| | Ecological Momentary Assessment | 1 | 2025 | 49 | 0.050 |
Why?
| | Bioprinting | 1 | 2025 | 33 | 0.050 |
Why?
| | Methacrylates | 1 | 2025 | 119 | 0.050 |
Why?
| | Neurons | 1 | 2014 | 1644 | 0.050 |
Why?
| | Enterotoxins | 1 | 2004 | 89 | 0.050 |
Why?
| | Valosin Containing Protein | 3 | 2009 | 8 | 0.050 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2021 | 3918 | 0.050 |
Why?
| | Interleukin-15 | 1 | 2025 | 95 | 0.050 |
Why?
| | Smoke-Free Policy | 1 | 2024 | 13 | 0.050 |
Why?
| | Nephritis | 1 | 2004 | 22 | 0.050 |
Why?
| | Opportunistic Infections | 1 | 2004 | 47 | 0.050 |
Why?
| | Bacterial Toxins | 1 | 2004 | 108 | 0.050 |
Why?
| | Acridine Orange | 1 | 2004 | 4 | 0.050 |
Why?
| | Intestine, Large | 1 | 2004 | 13 | 0.050 |
Why?
| | Nucleocapsid Proteins | 1 | 2023 | 28 | 0.050 |
Why?
| | Cell Proliferation | 2 | 2026 | 2504 | 0.050 |
Why?
| | Blood Coagulation | 1 | 2026 | 274 | 0.050 |
Why?
| | Disease Outbreaks | 2 | 2022 | 419 | 0.050 |
Why?
| | Risk Assessment | 2 | 2010 | 3740 | 0.050 |
Why?
| | Universities | 1 | 2026 | 443 | 0.050 |
Why?
| | Plasmids | 2 | 2018 | 373 | 0.050 |
Why?
| | Virulence Factors | 1 | 2004 | 174 | 0.050 |
Why?
| | Endothelial Cells | 2 | 2020 | 873 | 0.050 |
Why?
| | Inclusion Bodies, Viral | 1 | 2002 | 3 | 0.050 |
Why?
| | Dopaminergic Neurons | 1 | 2023 | 68 | 0.050 |
Why?
| | Viral Structural Proteins | 1 | 2002 | 12 | 0.050 |
Why?
| | Orthopoxvirus | 1 | 2002 | 4 | 0.050 |
Why?
| | Glycolysis | 1 | 2025 | 340 | 0.050 |
Why?
| | Immunoblotting | 2 | 2016 | 295 | 0.050 |
Why?
| | Escherichia coli Proteins | 1 | 2004 | 201 | 0.050 |
Why?
| | Light | 1 | 2025 | 403 | 0.050 |
Why?
| | Gene Deletion | 2 | 2018 | 391 | 0.050 |
Why?
| | Adenine | 1 | 2025 | 338 | 0.050 |
Why?
| | Rejuvenation | 1 | 2022 | 18 | 0.050 |
Why?
| | Epithelial Cells | 1 | 2008 | 1127 | 0.040 |
Why?
| | Vero Cells | 1 | 2022 | 83 | 0.040 |
Why?
| | HIV-1 | 1 | 2008 | 906 | 0.040 |
Why?
| | Clinical Trials, Phase II as Topic | 1 | 2021 | 75 | 0.040 |
Why?
| | Fracture Healing | 1 | 2022 | 91 | 0.040 |
Why?
| | Thymocytes | 1 | 2021 | 33 | 0.040 |
Why?
| | Ki-67 Antigen | 1 | 2022 | 117 | 0.040 |
Why?
| | Kidney Tubular Necrosis, Acute | 1 | 2021 | 26 | 0.040 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2025 | 932 | 0.040 |
Why?
| | Gene Knockout Techniques | 1 | 2022 | 117 | 0.040 |
Why?
| | Trastuzumab | 1 | 2022 | 118 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2024 | 740 | 0.040 |
Why?
| | Intubation, Gastrointestinal | 1 | 2022 | 81 | 0.040 |
Why?
| | Impulsive Behavior | 1 | 2022 | 145 | 0.040 |
Why?
| | Biofilms | 1 | 2004 | 292 | 0.040 |
Why?
| | United Kingdom | 1 | 2022 | 336 | 0.040 |
Why?
| | Fasting | 1 | 2022 | 276 | 0.040 |
Why?
| | Transcription Factors | 1 | 2009 | 1731 | 0.040 |
Why?
| | Lymphocyte Activation | 1 | 2025 | 1131 | 0.040 |
Why?
| | Graft Rejection | 1 | 2004 | 518 | 0.040 |
Why?
| | Belgium | 1 | 2020 | 11 | 0.040 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 129 | 0.040 |
Why?
| | Recombination, Genetic | 2 | 2017 | 203 | 0.040 |
Why?
| | Cooperative Behavior | 1 | 2023 | 461 | 0.040 |
Why?
| | Treatment Outcome | 3 | 2021 | 11741 | 0.040 |
Why?
| | Quinazolines | 1 | 2022 | 266 | 0.040 |
Why?
| | Colorado | 1 | 2010 | 4538 | 0.040 |
Why?
| | Tendon Injuries | 1 | 2021 | 73 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2025 | 733 | 0.040 |
Why?
| | CRISPR-Cas Systems | 1 | 2022 | 166 | 0.040 |
Why?
| | Escherichia coli | 1 | 2004 | 834 | 0.040 |
Why?
| | Chloroquine | 2 | 2010 | 54 | 0.040 |
Why?
| | Genetic Association Studies | 1 | 2022 | 367 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2021 | 410 | 0.040 |
Why?
| | Platelet Aggregation | 1 | 2020 | 99 | 0.040 |
Why?
| | Endothelium | 1 | 2020 | 119 | 0.040 |
Why?
| | Myofibroblasts | 1 | 2021 | 144 | 0.040 |
Why?
| | Aggression | 1 | 2021 | 178 | 0.040 |
Why?
| | Patient Care | 1 | 2021 | 119 | 0.040 |
Why?
| | RNA Interference | 2 | 2013 | 474 | 0.040 |
Why?
| | Pilot Projects | 1 | 2025 | 1889 | 0.040 |
Why?
| | Education | 1 | 2020 | 104 | 0.040 |
Why?
| | Microtubule-Associated Proteins | 2 | 2010 | 194 | 0.040 |
Why?
| | Contraception | 1 | 2021 | 170 | 0.040 |
Why?
| | Tissue Embedding | 1 | 2018 | 4 | 0.040 |
Why?
| | Pinocytosis | 1 | 2018 | 6 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2022 | 611 | 0.040 |
Why?
| | Neoadjuvant Therapy | 1 | 2022 | 465 | 0.040 |
Why?
| | Mutation Accumulation | 1 | 2018 | 1 | 0.040 |
Why?
| | Clathrin | 1 | 2018 | 26 | 0.040 |
Why?
| | Electricity | 1 | 2018 | 26 | 0.040 |
Why?
| | Energy Metabolism | 1 | 2025 | 933 | 0.040 |
Why?
| | Digoxin | 1 | 2018 | 27 | 0.040 |
Why?
| | Adrenal Cortex Hormones | 1 | 2022 | 483 | 0.040 |
Why?
| | Cell Culture Techniques | 1 | 2021 | 372 | 0.040 |
Why?
| | Hunger | 1 | 2019 | 56 | 0.030 |
Why?
| | Cultural Characteristics | 1 | 2018 | 69 | 0.030 |
Why?
| | Zebrafish Proteins | 1 | 2022 | 314 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2022 | 530 | 0.030 |
Why?
| | GPI-Linked Proteins | 1 | 2018 | 81 | 0.030 |
Why?
| | Viral Load | 2 | 2012 | 525 | 0.030 |
Why?
| | Drosophila | 1 | 2019 | 164 | 0.030 |
Why?
| | Veins | 1 | 2018 | 69 | 0.030 |
Why?
| | Germ Cells | 1 | 2018 | 65 | 0.030 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2018 | 106 | 0.030 |
Why?
| | Postpartum Period | 1 | 2021 | 372 | 0.030 |
Why?
| | Physician Assistants | 1 | 2020 | 101 | 0.030 |
Why?
| | Decision Making | 1 | 2025 | 974 | 0.030 |
Why?
| | Lymph Node Excision | 1 | 2019 | 173 | 0.030 |
Why?
| | Lymphatic Metastasis | 1 | 2019 | 331 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2025 | 3114 | 0.030 |
Why?
| | Polymerase Chain Reaction | 2 | 2012 | 1039 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 1 | 2008 | 2767 | 0.030 |
Why?
| | Computer-Assisted Instruction | 1 | 2018 | 69 | 0.030 |
Why?
| | Microtubules | 1 | 2019 | 265 | 0.030 |
Why?
| | Biological Transport | 1 | 2018 | 423 | 0.030 |
Why?
| | Glucose | 1 | 2022 | 1048 | 0.030 |
Why?
| | Self Efficacy | 1 | 2021 | 410 | 0.030 |
Why?
| | Gene Transfer Techniques | 1 | 2018 | 186 | 0.030 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2009 | 212 | 0.030 |
Why?
| | Attitude of Health Personnel | 1 | 2025 | 1186 | 0.030 |
Why?
| | Survival Analysis | 1 | 2020 | 1371 | 0.030 |
Why?
| | Binding Sites | 1 | 2020 | 1309 | 0.030 |
Why?
| | Prognosis | 2 | 2018 | 4310 | 0.030 |
Why?
| | Faculty | 1 | 2018 | 147 | 0.030 |
Why?
| | Signal Transduction | 2 | 2025 | 5208 | 0.030 |
Why?
| | Sarcolemma | 2 | 2007 | 35 | 0.030 |
Why?
| | Isolated Heart Preparation | 1 | 2016 | 6 | 0.030 |
Why?
| | Schools, Medical | 1 | 2018 | 159 | 0.030 |
Why?
| | Quality Improvement | 1 | 2025 | 1293 | 0.030 |
Why?
| | Mutant Proteins | 2 | 2007 | 105 | 0.030 |
Why?
| | Microfilament Proteins | 2 | 2008 | 135 | 0.030 |
Why?
| | Organizational Culture | 1 | 2018 | 161 | 0.030 |
Why?
| | Neutrophils | 1 | 2022 | 1123 | 0.030 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2016 | 112 | 0.030 |
Why?
| | Gene Expression Regulation, Bacterial | 2 | 2009 | 337 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2008 | 977 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-sis | 2 | 2006 | 38 | 0.030 |
Why?
| | Granuloma | 1 | 2016 | 97 | 0.030 |
Why?
| | Cues | 1 | 2018 | 327 | 0.030 |
Why?
| | Eating | 1 | 2019 | 387 | 0.030 |
Why?
| | Nutritional Status | 1 | 2018 | 353 | 0.030 |
Why?
| | Patient Safety | 1 | 2020 | 355 | 0.030 |
Why?
| | Blood Glucose Self-Monitoring | 1 | 2021 | 699 | 0.030 |
Why?
| | Energy Intake | 1 | 2019 | 507 | 0.030 |
Why?
| | California | 1 | 2017 | 471 | 0.030 |
Why?
| | ErbB Receptors | 1 | 2019 | 635 | 0.030 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2016 | 138 | 0.030 |
Why?
| | Necrosis | 1 | 2016 | 243 | 0.030 |
Why?
| | Collagen Type I | 2 | 2006 | 143 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2022 | 1146 | 0.030 |
Why?
| | Stress, Mechanical | 1 | 2017 | 494 | 0.030 |
Why?
| | Amino Acid Transport Systems, Basic | 1 | 2014 | 4 | 0.030 |
Why?
| | Cadherins | 1 | 2016 | 200 | 0.030 |
Why?
| | Placenta | 1 | 2021 | 784 | 0.030 |
Why?
| | Myocardial Contraction | 1 | 2016 | 291 | 0.030 |
Why?
| | Focus Groups | 1 | 2018 | 569 | 0.030 |
Why?
| | Thy-1 Antigens | 1 | 2014 | 11 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2019 | 1109 | 0.030 |
Why?
| | Channelrhodopsins | 1 | 2014 | 19 | 0.030 |
Why?
| | Mentoring | 1 | 2017 | 165 | 0.030 |
Why?
| | Alleles | 1 | 2017 | 888 | 0.030 |
Why?
| | Activating Transcription Factor 6 | 1 | 2014 | 19 | 0.030 |
Why?
| | HeLa Cells | 2 | 2008 | 631 | 0.030 |
Why?
| | Primates | 1 | 2014 | 133 | 0.030 |
Why?
| | Corpus Callosum | 1 | 2014 | 72 | 0.030 |
Why?
| | Interviews as Topic | 1 | 2018 | 907 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2014 | 302 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2018 | 1058 | 0.020 |
Why?
| | Emotions | 1 | 2019 | 573 | 0.020 |
Why?
| | Apoptosis | 1 | 2022 | 2434 | 0.020 |
Why?
| | Mycobacterium tuberculosis | 1 | 2016 | 318 | 0.020 |
Why?
| | Base Pairing | 1 | 2013 | 65 | 0.020 |
Why?
| | Cell Survival | 1 | 2016 | 1100 | 0.020 |
Why?
| | Blotting, Northern | 1 | 2013 | 203 | 0.020 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2013 | 74 | 0.020 |
Why?
| | Peritoneal Cavity | 1 | 2012 | 30 | 0.020 |
Why?
| | Mitochondrial Membranes | 1 | 2013 | 40 | 0.020 |
Why?
| | Nephritis, Hereditary | 1 | 2012 | 3 | 0.020 |
Why?
| | Cell Respiration | 1 | 2013 | 105 | 0.020 |
Why?
| | Recombinant Proteins | 2 | 2006 | 1368 | 0.020 |
Why?
| | Progestins | 1 | 2013 | 66 | 0.020 |
Why?
| | Cerebral Infarction | 1 | 2012 | 47 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2012 | 196 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2021 | 2588 | 0.020 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 1958 | 0.020 |
Why?
| | RNA Splicing | 1 | 2014 | 284 | 0.020 |
Why?
| | Cell Lineage | 1 | 2014 | 377 | 0.020 |
Why?
| | Dietary Supplements | 1 | 2016 | 582 | 0.020 |
Why?
| | DNA | 1 | 2018 | 1433 | 0.020 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2012 | 73 | 0.020 |
Why?
| | Endoplasmic Reticulum | 1 | 2014 | 264 | 0.020 |
Why?
| | Protein Transport | 1 | 2013 | 441 | 0.020 |
Why?
| | Muscle Denervation | 1 | 2010 | 8 | 0.020 |
Why?
| | Colchicine | 1 | 2010 | 21 | 0.020 |
Why?
| | Tubulin Modulators | 1 | 2010 | 11 | 0.020 |
Why?
| | Evolution, Molecular | 1 | 2014 | 490 | 0.020 |
Why?
| | Host-Pathogen Interactions | 1 | 2014 | 361 | 0.020 |
Why?
| | Mitochondrial Proteins | 1 | 2013 | 263 | 0.020 |
Why?
| | Vinblastine | 1 | 2010 | 75 | 0.020 |
Why?
| | Hemorrhagic Septicemia, Viral | 1 | 2010 | 1 | 0.020 |
Why?
| | Mesomycetozoea | 1 | 2010 | 1 | 0.020 |
Why?
| | Mesomycetozoea Infections | 1 | 2010 | 1 | 0.020 |
Why?
| | Pacific Ocean | 1 | 2010 | 8 | 0.020 |
Why?
| | Ulcer | 1 | 2010 | 37 | 0.020 |
Why?
| | Calcium | 1 | 2016 | 1189 | 0.020 |
Why?
| | Sequestosome-1 Protein | 1 | 2009 | 15 | 0.020 |
Why?
| | Qualitative Research | 1 | 2018 | 1671 | 0.020 |
Why?
| | Genes, Dominant | 1 | 2010 | 100 | 0.020 |
Why?
| | Biomarkers | 1 | 2021 | 4282 | 0.020 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2018 | 1415 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2013 | 728 | 0.020 |
Why?
| | Tissue Extracts | 1 | 2009 | 19 | 0.020 |
Why?
| | Population Dynamics | 1 | 2010 | 142 | 0.020 |
Why?
| | Age Distribution | 1 | 2010 | 402 | 0.020 |
Why?
| | Motor Activity | 1 | 2014 | 718 | 0.020 |
Why?
| | Protein Structure, Quaternary | 1 | 2009 | 116 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2010 | 396 | 0.020 |
Why?
| | Heat-Shock Proteins | 1 | 2009 | 139 | 0.020 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2009 | 88 | 0.020 |
Why?
| | Synovial Fluid | 1 | 2008 | 67 | 0.020 |
Why?
| | Caliciviridae Infections | 1 | 2008 | 18 | 0.020 |
Why?
| | Isoleucine | 1 | 2008 | 15 | 0.020 |
Why?
| | Blotting, Southern | 1 | 2008 | 84 | 0.020 |
Why?
| | Threonine | 1 | 2008 | 44 | 0.020 |
Why?
| | Fibroblasts | 1 | 2014 | 1022 | 0.020 |
Why?
| | Monte Carlo Method | 1 | 2008 | 147 | 0.020 |
Why?
| | Laparoscopy | 1 | 2012 | 481 | 0.020 |
Why?
| | Dimerization | 1 | 2008 | 189 | 0.020 |
Why?
| | Antirheumatic Agents | 1 | 2010 | 307 | 0.020 |
Why?
| | Oxygen | 1 | 2013 | 978 | 0.020 |
Why?
| | Myosins | 1 | 2008 | 132 | 0.020 |
Why?
| | Sirolimus | 1 | 2009 | 280 | 0.020 |
Why?
| | Cohort Studies | 1 | 2018 | 5988 | 0.020 |
Why?
| | Respiratory Insufficiency | 1 | 2010 | 326 | 0.020 |
Why?
| | Stress, Physiological | 1 | 2010 | 443 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2009 | 666 | 0.020 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2009 | 425 | 0.020 |
Why?
| | Cell Death | 1 | 2008 | 382 | 0.020 |
Why?
| | Chronic Disease | 1 | 2012 | 1806 | 0.020 |
Why?
| | Connectin | 1 | 2006 | 42 | 0.020 |
Why?
| | Organ Specificity | 1 | 2007 | 308 | 0.010 |
Why?
| | Guided Tissue Regeneration, Periodontal | 1 | 2006 | 1 | 0.010 |
Why?
| | Alveolar Bone Loss | 1 | 2006 | 9 | 0.010 |
Why?
| | Base Sequence | 1 | 2010 | 2168 | 0.010 |
Why?
| | Calcium Phosphates | 1 | 2006 | 28 | 0.010 |
Why?
| | Bone Substitutes | 1 | 2006 | 26 | 0.010 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2007 | 155 | 0.010 |
Why?
| | Genetic Engineering | 1 | 2006 | 88 | 0.010 |
Why?
| | Tissue Distribution | 1 | 2006 | 335 | 0.010 |
Why?
| | Physical Conditioning, Animal | 1 | 2008 | 242 | 0.010 |
Why?
| | Models, Genetic | 1 | 2008 | 523 | 0.010 |
Why?
| | Muscles | 1 | 2006 | 330 | 0.010 |
Why?
| | Caveolins | 1 | 2004 | 5 | 0.010 |
Why?
| | Periplasm | 1 | 2004 | 13 | 0.010 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2004 | 45 | 0.010 |
Why?
| | HT29 Cells | 1 | 2004 | 37 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2013 | 2803 | 0.010 |
Why?
| | Caveolin 1 | 1 | 2004 | 20 | 0.010 |
Why?
| | Membrane Microdomains | 1 | 2004 | 34 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2009 | 1244 | 0.010 |
Why?
| | Specimen Handling | 1 | 2006 | 182 | 0.010 |
Why?
| | Methylprednisolone | 1 | 2004 | 59 | 0.010 |
Why?
| | Antibodies, Viral | 1 | 2008 | 673 | 0.010 |
Why?
| | Regeneration | 1 | 2006 | 197 | 0.010 |
Why?
| | Papio | 1 | 2004 | 70 | 0.010 |
Why?
| | Virulence | 1 | 2004 | 278 | 0.010 |
Why?
| | Phosphorylation | 1 | 2008 | 1706 | 0.010 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2006 | 552 | 0.010 |
Why?
| | Muscle Contraction | 1 | 2006 | 429 | 0.010 |
Why?
| | Cowpox virus | 1 | 2002 | 2 | 0.010 |
Why?
| | Genetic Complementation Test | 1 | 2002 | 72 | 0.010 |
Why?
| | Vaccinia virus | 1 | 2002 | 35 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2009 | 1454 | 0.010 |
Why?
| | Drug Delivery Systems | 1 | 2006 | 380 | 0.010 |
Why?
| | Immunoglobulin A | 1 | 2004 | 214 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2006 | 693 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2009 | 1479 | 0.010 |
Why?
| | Protein Binding | 1 | 2008 | 2235 | 0.010 |
Why?
| | Gene Expression | 1 | 2007 | 1474 | 0.010 |
Why?
| | Public Health | 1 | 2006 | 571 | 0.010 |
Why?
| | Glucocorticoids | 1 | 2004 | 531 | 0.010 |
Why?
| | Viral Proteins | 1 | 2002 | 350 | 0.010 |
Why?
| | Immunosuppressive Agents | 1 | 2004 | 837 | 0.010 |
Why?
| | Communication | 1 | 2006 | 973 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2002 | 2127 | 0.010 |
Why?
| | Disease Progression | 1 | 2006 | 2857 | 0.010 |
Why?
| | Bacteria | 1 | 2004 | 765 | 0.010 |
Why?
| | Algorithms | 1 | 2006 | 1845 | 0.010 |
Why?
| | Incidence | 1 | 2004 | 2915 | 0.010 |
Why?
| | Time Factors | 1 | 2008 | 7107 | 0.010 |
Why?
|
|
Miller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|